At Viralgen, we maintain two manufacturing facilities separated by a short walk from one another:
Our first facility, opened in 2018, maintains 4 cGMP production suites able to produce between 250-500L in a run and up to 1500L per batch, along with fill and finish all in independent suites and carrying EMEA cGMP certification for manufacturing up to phase 3 clinical trials. Quality control and development labs are also housed within the ~45,000 square foot facility.
Our second facility, opened in 2021, houses 3 independent modules each containing 3 production trains, along with fill and finish, warehousing, and QC labs to support late phase and commercial manufacturing. In total, the facility houses 9 production suites each with up to 2,000L single-use bioreactors. This facility is more than 300,000 square feet of total space for AAV production, making it the largest facility dedicated to AAV production in the world.
Do you want to know more about how we can help you?